Even measured against the vast scientific mystery that defines the biotech industry, cell and gene therapy poses extraordinary challenges. To achieve operational excellence in these trials, you must understand — and overcome — obstacles ranging from start-up regulations and site selection to patient recruitment and retention. And given the limited data on the long-term effects of these therapies, participants in cell and gene therapy trials may be monitored for a long-term follow-up period, which may be as long as 10 years. For projects of this scale, you need a partner that can deliver from start to finish. That’s where FERVOR comes in.
FERVOR has the experience and end-to-end expertise to help you advance your development program, informed by over a decade of work in these highly specialized clinical trials. In this pioneering development space, FERVOR can help you better predict how patients, caregivers, sites, regulators and payers will react to your therapy.
